Each dose is given 2 months (56 days) apart.Ĭhildren aged five to 11 years of age will be offered the 10-mcg dose of the Pfizer-BioNTech COVID-19 vaccine to start their vaccine series.Ĭhildren who started a Moderna Spikevax 25 mcg vaccine series will generally complete the primary series with a second Moderna Spikevax dose. Each dose is given at least two months (56 days) apart.Ĭhildren aged six months to four years may be offered the Moderna Spikevax (25 microgram ) dose. The vaccine your child gets will depend on availability and supply.Ĭhildren aged six months to four years may be offered the Pfizer BioNTech 3mcg COVID-19 vaccine. There are two different mRNA vaccines available to children six months of age and older. Getting your vaccination will give you greater protection against serious illness and hospitalization from COVID-19. Learn more about Ottawa Public Health's plan to offer COVID-19 vaccines to children ages six months to 11 years oldįor children aged six months to under five years, OPH recommends a vaccine appointment, to make sure the proper dose is available. The SickKids COVID-19 Vaccine Consult Service is a by-appointment phone service that provides a safe, judgment-free space to have an open conversation about the COVID-19 vaccine. Why should my 6 months to 5-year-old get the COVID-19 vaccine? On December 9, 2022, NACI updated their guidance now recommending that COVID-19 vaccines may be given on the same day as or at any time before or after non-COVID-19 vaccines for children 6 months to 5 years of age. There is no mixing of COVID-19 vaccine products from different manufacturers for children six months to five years however, if a child turns five and has not completed the series, they will be provided with the higher dose product appropriate for their age. The recommended interval between doses is two months (56 days) between dose one and two, and two months (56 days) between dose two and three.įor children who start their primary series with the Pfizer-BioNTech COVID-19 (3 mcg dose), they must also get a Pfizer-BioNTech COVID-19 product for their second and third doses. People aged 12 years and up who previously received one or more doses of Novavax COVID-19 vaccine are recommended to receive one bivalent mRNA vaccine dose at least 8 weeks after their last monovalent dose.Health Canada has approved the Pfizer-BioNTech COVID-19 vaccine (3mcg) for children six months to four years of age.An 8-week interval between the first and second primary series doses might be optimal for some people ages 6 months–64 years, especially for males 12–39 years old. The second of the two doses should be administered 3-8 weeks after the first dose. Novavax can be used as a two-dose primary series for individuals 12+ years old.** The monovalent Novavax COVID-19 vaccine remains authorized for the following scenarios: Minimum 2-month (60-day) interval after bivalent dose 1 ( optional)Īt least 2 months after bivalent dose 2 ( optional)Ģ doses monovalent Moderna, with no bivalent dosesģ doses monovalent Moderna, with no bivalent dosesģ doses monovalent Pfizer-BioNTech, with no bivalent dosesĮver received at least 1 dose bivalent Moderna or Pfizer-BioNTechģ doses monovalent Moderna or 3 doses monovalent Pfizer-BioNTech, with no bivalent dosesĪt least 3 doses of monovalent Moderna or Pfizer-BioNTech, with no bivalent doses Minimum 2-month (60-day) interval after bivalent dose 2 ( optional) (21-day) interval after last monovalent doseĢ doses monovalent Pfizer-BioNTech, with no bivalent dosesģ doses of Pfizer-BioNTech, with no bivalent dosesĮver received at least 1 bivalent dose of Moderna or Pfizer-BioNTech (56-day) interval after last monovalent doseġ dose monovalent Pfizer-BioNTech, with no bivalent doses Minimum 2-month (60-day) interval ( optional)ģ doses of monovalent Moderna, with no bivalent doses Minimum 2-month (60-day) interval ( optional)*Ģ or more doses monovalent Moderna, with no bivalent doses (28-day) interval after last monovalent dose Where possible, the additional dose(s) should be homologous (should match) with previous doses given.ĭosing Schedule: Immunocompromised, Any History of COVID-19 Vaccinationġ dose monovalent Moderna, with no bivalent doses Any further doses should be administered at least 2 months following the most recent COVID-19 vaccine dose. * For moderately to severely immunocompromised individuals, further additional dose(s) may be administered based on clinical judgment of a health care provider and personal preference/circumstances. Are unable or unwilling to receive an mRNA vaccine and would not otherwise receive a booster dose.ĭosing Schedule: Immunocompromised, No History of COVID-19 Vaccination
0 Comments
Leave a Reply. |